Success Metrics

Clinical Success Rate
88.1%

Based on 222 completed trials

Completion Rate
88%(222/252)
Active Trials
78(18%)
Results Posted
43%(96 trials)
Terminated
30(7%)

Phase Distribution

Ph phase_3
34
8%
Ph phase_4
8
2%
Ph early_phase_1
3
1%
Ph phase_1
18
4%
Ph not_applicable
312
72%
Ph phase_2
58
13%

Phase Distribution

21

Early Stage

58

Mid Stage

42

Late Stage

Phase Distribution433 total trials
Early Phase 1First-in-human
3(0.7%)
Phase 1Safety & dosage
18(4.2%)
Phase 2Efficacy & side effects
58(13.4%)
Phase 3Large-scale testing
34(7.9%)
Phase 4Post-market surveillance
8(1.8%)
N/ANon-phased studies
312(72.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.4%

222 of 260 finished

Non-Completion Rate

14.6%

38 ended early

Currently Active

78

trials recruiting

Total Trials

434

all time

Status Distribution
Active(97)
Completed(222)
Terminated(38)
Other(77)

Detailed Status

Completed222
unknown74
Recruiting65
Terminated30
Not yet recruiting17
Active, not recruiting13

Development Timeline

Analytics

Development Status

Total Trials
434
Active
78
Success Rate
88.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (0.7%)
Phase 118 (4.2%)
Phase 258 (13.4%)
Phase 334 (7.9%)
Phase 48 (1.8%)
N/A312 (72.1%)

Trials by Status

completed22251%
unknown7417%
withdrawn82%
recruiting6515%
active_not_recruiting133%
not_yet_recruiting174%
enrolling_by_invitation20%
terminated307%
suspended31%

Recent Activity

Clinical Trials (434)

Showing 20 of 434 trialsScroll for more
NCT06559891Not Applicable

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Recruiting
NCT07524010Not Applicable

Multi-Omics Characterization of Percutaneous Electrolysis in Low Back Pain

Enrolling By Invitation
NCT05456282Not Applicable

Acute Effects of AMPS on Cardiovascular, Functional Capacity and Postural Control in Patients With Parkinson's Disease

Completed
NCT07558928Not Applicable

Effect of Hyperoxygenated Environment on Maximal Muscle Strength

Recruiting
NCT06627283Not Applicable

Effects of Respiratory Muscle Training on Tongue Muscle Function

Recruiting
NCT06778447Not Applicable

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

Recruiting
NCT06282406Not Applicable

Pupil-Indexed Noninvasive Neuromodulation

Recruiting
NCT07476469Not Applicable

tVNS and Approach-Avoidance Behavior in Anhedonia and Anxiety

Recruiting
NCT05851326Not Applicable

Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome

Recruiting
NCT04647656Not Applicable

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

Recruiting
NCT07399301Not Applicable

High-Intensity Functional Training on Physical Performance and Mental Health in Elderly With Sarcopenia

Not Yet Recruiting
NCT05642325Phase 3

Vamikibart in Participants With Uveitic Macular Edema

Completed
NCT06990815Not Applicable

Immediate Effects of Kinesio Taping in Primary Dysmenorrhea

Completed
NCT03364153Phase 2

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Completed
NCT06100185Not Applicable

Wearable Transcranial Electrical Stimulation (tES) for Insomnia

Active Not Recruiting
NCT07411846Not Applicable

tAVNS for Stress Reduction in University Students

Completed
NCT04122001Not Applicable

Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease

Active Not Recruiting
NCT04725201Phase 4

Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization

Recruiting
NCT03664531Not Applicable

Dietary Triggers of Gastrointestinal Symptoms in IBS Patients

Completed
NCT03945058Not Applicable

Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

Terminated

Drug Details

Intervention Type
OTHER
Total Trials
434